ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis

Mallio, Carlo Augusto*; Napolitano, Andrea*; Castiello, Gennaro; Giordano, Francesco Maria; D'Alessio, Pasquale; Iozzino, Mario; Sun, Yipeng; Angeletti, Silvia; Russano, Marco; Santini, Daniele; Tonini, Giuseppe; Zobel, Bruno Beomonte; Vincenzi, Bruno; Quattrocchi, Carlo Cosimo
Cancers2021-2DOI: 10.3390/cancers13040652
20被引6阅读
引用收藏
分享

摘要

Simple Summary The use of immune checkpoint inhibitors (ICIs) to treat oncologic diseases is progressively increasing. Computed tomography (CT) features of ICI therapy-related pneumonitis may overlap with other diseases, including coronavirus disease 2019 (COVID-19). Thus, oncologic patients undergoing ICI therapy and developing pneumonitis are at risk of being misdiagnosed. Exploring the strengths and weaknesses of artificial intelligence in distinguishing between ICI therapy-related pneumonitis and COVID-19 is of great importance for oncologic patients and for clinicians in order to increase awareness on this topic and stimulate novel strategies aimed to promptly and correctly classify and treat this category of vulnerable patients. Background: Coronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolutional neural network algorithm is able to solve the challenge of differential diagnosis between COVID-19 pneumonia and ICI therapy-related pneumonitis. Methods: We enrolled three groups: a pneumonia-free group (n = 30), a COVID-19 group (n = 34), and a group of patients with ICI therapy-related pneumonitis (n = 21). Computed tomography images were analyzed with an artificial intelligence (AI) algorithm based on a deep convolutional neural network structure. Statistical analysis included the Mann-Whitney U test (significance threshold at p < 0.05) and the receiver operating characteristic curve (ROC curve). Results: The algorithm showed low specificity in distinguishing COVID-19 from ICI therapy-related pneumonitis (sensitivity 97.1%, specificity 14.3%, area under the curve (AUC) = 0.62). ICI therapy-related pneumonitis was identified by the AI when compared to pneumonia-free controls (sensitivity = 85.7%, specificity 100%, AUC = 0.97). Conclusions: The deep learning algorithm is not able to distinguish between COVID-19 pneumonia and ICI therapy-related pneumonitis. Awareness must be increased among clinicians about imaging similarities between COVID-19 and ICI therapy-related pneumonitis. ICI therapy-related pneumonitis can be applied as a challenge population for cross-validation to test the robustness of AI models used to analyze interstitial pneumonias of variable etiology.

学科与关键词

关键词
artificial intelligenceCOVID-19deep learningchest CTimmune checkpoint inhibitors therapydrug-induced pneumonitis
相关
加载中…
  • Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer
    Cheng, M.; Lin, R.; Bai, N.; Zhang, Y.; Wang, H.; Guo, M.; Duan, X.; Zheng, J.*; Qiu, Z.*; Zhao, Y.*Clinical Radiology, 2023, 78(5): e377-e385.被引 2
  • Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience
    Lin, Xinqing; Deng, Haiyi; Chen, Likun; Wu, Di; Chen, Xiaobo; Yang, Yilin; Chen, Tao; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Ouyang, Ming; Qin, Yinyin; Li, Shiyue; Zhong, Nanshan; Gregg, Jeffrey P.; Horita, Nobuyuki; Song, Yong*; Zhou, Chengzhi*Translational Lung Cancer Research, 2021, 10(1): 415-429.被引 12
  • Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
    Lin, Xinqing; Deng, Jiaxi; Deng, Haiyi; Yang, Yilin; Sun, Ni; Zhou, Maolin; Qin, Yinyin; Xie, Xiaohong; Li, Shiyue; Zhong, Nanshan; Song, Yong*; Zhou, Chengzhi*Frontiers in Immunology, 2022, 12: 818492.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancers
发表日期
2021-02
卷期
第 13 卷, 第 4 期
页码
652
DOI
10.3390/cancers13040652
期刊收录
NSL
期刊等级
2区
成果收录
SCIE

作者

  • M

    Mallio, Carlo Augusto (通讯) (第一作者)

  • N

    Napolitano, Andrea (通讯)

查看全部 14 位作者收起作者
  • C

    Castiello, Gennaro

  • G

    Giordano, Francesco Maria

  • D

    D'Alessio, Pasquale

  • I

    Iozzino, Mario

  • S

    Sun, Yipeng

  • A

    Angeletti, Silvia

  • R

    Russano, Marco

  • S

    Santini, Daniele

  • T

    Tonini, Giuseppe

  • Z

    Zobel, Bruno Beomonte

  • V

    Vincenzi, Bruno

  • Q

    Quattrocchi, Carlo Cosimo

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417